FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis

Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood Children treated with Dupixent and topical corticosteroids (TCS) achieved clearer skin, and significantly reduced...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news